Considering the importance of adipokines in the pathophysiology of non-alcoholic fatty liver
disease (NAFLD), and due to the possible beneficial effects of α-lipoic acid (α-LA) on these …

What is known and objective Non‐alcoholic fatty liver disease (NAFLD) is the most common
cause of chronic liver injury. Some animal studies suggest that alpha‐lipoic acid (ALA) can …

Background: Insulin resistance has a pivotal role in the occurrence of impaired glucose
tolerance and dyslipidemia in patients with Non-Alcoholic Fatty Liver Disease (NAFLD) …

Background To compare the effects of α-lipoic acid (ALA), myo-inositol (MI) and propolis
supplementation on metabolic parameters and liver function in obese patients with non …

Background and purpose Nonalcoholic fatty liver disease (NAFLD) is one of the causes of a
fatty liver, occurring when fat is deposited (steatosis) in the liver not due to excessive alcohol …

Background: Several mechanisms have been suggested to explain the pathogenesis of
nonalcoholic fatty liver disease (NAFLD) and its progression, one of which is increased …

Scope Effective treatment for obesity associated non‐alcoholic fatty liver disease (NAFLD) is
limited. Dietary supplementation of n‐3 polyunsaturated fatty acids, specifically alpha …

Background. Coronary artery disease is the most common cause of death in the patients
with nonalcoholic fatty liver disease (NAFLD). Studies have shown that there is a strong …

Background and objectives Nonalcoholic fatty liver disease (NAFLD) management is
focused on lifestyle modifications, but long‐term maintenance is a challenge for many …

Nonalcoholic fatty liver disease (NAFLD) is characterized by fat deposition in hepatocytes,
and a strong association with nutritional factors. Dietary fatty acids are classified according …